Subcutaneous Immunoglobulin (SCig) for Maintenance Therapy in Severe POTS: A Case Report.
DOI:
https://doi.org/10.46570/utjms.vol11-2023-938References
Sheldon RS, Grubb BP II, Olshansky B, Shen WK, Calkins H, Brignole M et al (2015) 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. 2015 Jun;12(6):e41-63. doi: 10.1016/j.hrthm.2015.03.029. Epub 2015 May 14.
Ballow M. Safety of IGIV therapy and infusion-related adverse events. Immunol Res. 2007;38(1-3):122-32. doi: 10.1007/s12026-007-0003-5. PMID: 17917017.
Mohammed Ruzieh, Lillian Batizy, Osama Dasa, Carson Oostra & Blair Grubb (2017) The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review, Scandinavian Cardiovascular Journal, 51:5, 243-247, DOI: 10.1080/14017431.2017.1355068
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Tahrima Ferdous
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).